BE546388A - - Google Patents
Info
- Publication number
- BE546388A BE546388A BE546388DA BE546388A BE 546388 A BE546388 A BE 546388A BE 546388D A BE546388D A BE 546388DA BE 546388 A BE546388 A BE 546388A
- Authority
- BE
- Belgium
- Prior art keywords
- group
- hydrogen atom
- glucoside
- compounds
- glucosic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 10
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000000875 corresponding Effects 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000155 melt Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 150000008064 anhydrides Chemical class 0.000 description 5
- 238000005917 acylation reaction Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- NXVJTGLCCSFGAT-QNDDJFOYSA-N (5R,5aR,8aR,9R)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NXVJTGLCCSFGAT-QNDDJFOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butanoic acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- YJGVMLPVUAXIQN-XVVDYKMHSA-N Podophyllotoxin Chemical class COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 2
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N Propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 230000002927 anti-mitotic Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229960001237 podophyllotoxin Drugs 0.000 description 2
- 229930001140 podophyllotoxin Natural products 0.000 description 2
- -1 propionyl compound Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N Benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001066 destructive Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229950008597 drug INN Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE546388A true BE546388A (pt) |
Family
ID=173711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE546388D BE546388A (pt) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE546388A (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0320988A2 (en) * | 1987-12-18 | 1989-06-21 | Bristol-Myers Squibb Company | Epipodophyllotoxin glucoside 4'-acyl derivative |
-
0
- BE BE546388D patent/BE546388A/fr unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0320988A2 (en) * | 1987-12-18 | 1989-06-21 | Bristol-Myers Squibb Company | Epipodophyllotoxin glucoside 4'-acyl derivative |
EP0320988A3 (en) * | 1987-12-18 | 1990-08-22 | Bristol-Myers Squibb Company | Epipodophyllotoxin glucoside 4'-acyl derivative |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0064012B1 (fr) | Nouveaux disaccharides formés de motifs à structure glucosamine et acide uronique, leur préparation et leurs applications biologiques | |
JP2651414B2 (ja) | 4−デメントキシ−4−アミノ−アントラサイクリン類 | |
CH647523A5 (fr) | Solvats d'ethers alicycliques et d'un acide cephem-4-carboxylique, leur preparation et leur utilisation pour l'obtention de l'acide et de ses sels. | |
FI87655C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara -d-fenyltioxylosider | |
EP0310519B1 (fr) | Nouveaux esters d'acide androstane 17-carboxylique, procédé pour leur préparation et médicament les contenant | |
EP0421829B1 (fr) | Nouveaux benzopyranone-beta-D-thioxylosides, leur procédé de préparation et leur utilisation en thérapeutique | |
CH622528A5 (en) | Process for the preparation of aminoglycoside antibiotics | |
BE546388A (pt) | ||
JPH08269063A (ja) | ピリピロペン誘導体 | |
US4078137A (en) | Process for manufacturing a flavone derivative | |
CA1216283A (fr) | Amino-14 steroides, leur application en therapeutique et procede pour leur preparation | |
CA1216282A (fr) | Derives d'amino-14 steroides, procede pour leur preparation et application en therapeutique | |
JPS5821918B2 (ja) | 1−N−(α−置換−ω−アミノアシル)−3′−デオキシリ ボスタマイシンの新規な製造 | |
EP0292352A2 (fr) | Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques les contenant | |
BE883759A (fr) | Glycosides d'anthracycline | |
EP0082793B1 (fr) | Nouveaux dérivés à structure acide uronique, leur préparation et leurs applications biologiques | |
FR2500837A1 (fr) | Nouveaux derives a, b-(d)-n-glucosides ou a, b-(l)-n-glucosides d'aminoacridine, sels de ceux-ci, procede pour la preparation de composes de ce genre, et medicaments contenant ces composes | |
CH620688A5 (en) | Process for the preparation of new lactones derived from cyclopentanol | |
FR2590260A1 (fr) | Nitro-anthracycline, aglycone correspondante, procedes pour les preparer, composition pharmaceutique correspondante | |
JPH10503509A (ja) | 8−フルオロ−アントラサイクリン類、それらの調整法及びそれらを含む薬学的組成品 | |
FR2555587A1 (fr) | Derives de 14-des(hydroxymethyl)-mycaminosyltylonolide | |
JP2640239B2 (ja) | プロトスタ−13(17)エン−3,16−ジオン化合物 | |
JPH0717684B2 (ja) | 複合多糖およびその製造法 | |
BE887456R (fr) | Procede de production de composes intermediaires pour l'obtention de la spectinomycine et de ses analogues et produits de ce procede | |
BE547697A (pt) |